Qidni Labs
Qidni Labs Inc. is a pre-commercial medical device company developing Qartridge™, a proprietary selective-absorption cartridge, and the Qidni/D portable dialysis machine that performs hemodialysis without dialysate, purified water, or grid power, targeting the global population of kidney failure patients without access to conventional dialysis infrastructure.
- Company typePrivate
- Founded2014
- HeadquartersBuffalo, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Qidni Labs does
Qidni Labs Inc. is a privately held medical device company developing portable, infrastructure-independent hemodialysis technology. Founded in 2014 and headquartered across Buffalo, New York and Kitchener, Ontario, the company is led by founder and CEO Morteza Ahmadi and operates with fewer than 10 employees. Its stated objective is to address the up to 10 million kidney failure patients globally who lack access to dialysis, and its technology is targeted at rural populations, home dialysis candidates rejected due to inadequate water or electrical infrastructure, disaster response settings, satellite clinics, pandemic scenarios, and military or battlefield medical use.
The company's product platform is built around Qartridge™, a proprietary selective-absorption cartridge that removes uremic toxins and other solutes directly from whole blood, eliminating the need for the approximately 120 liters of dialysate and 300–500 liters of purified water required by conventional hemodialysis. The flagship device, Qidni/D, integrates this cartridge into one of the most miniaturized dialysis machines ever built, offering rechargeable battery operation, 3–4 hour treatment times comparable to standard hemodialysis, and cloud-based remote monitoring by the clinical team. Qartridge™ is positioned as a platform technology with stated optionality for selective removal of other solutes and biofluids beyond kidney applications.
Commercially, Qidni is pre-revenue: the company's own website states that Qidni devices and Qartridges are not approved by the US FDA or Health Canada and are not available for commercial sale. The intended revenue model combines hardware sales of the Qidni/D device, recurring revenue from single-use Qartridge™ consumables priced comparably to existing hemodialysis consumables, and licensing or partnership income from the underlying platform technology. The company has been financed through a mix of equity (SOSV/IndieBio, 43North, Sunhope Capital, ECO Angels/ECOAST Angels, China Canada Angel Alliance, Velocity) and non-dilutive capital (NRC IRAP, OBIO BDSP, L-SPARK, NATO DIANA), and is actively soliciting licensing and distribution partners as its primary go-to-market pathway.
Qidni Labs firmographics
Firmographics- Name
- Qidni Labs
- Legal name
- Qidni Labs Inc.
- Website
- https://qidni.life
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Qidni Labs Inc. is a pre-commercial medical device company developing Qartridge™, a proprietary selective-absorption cartridge, and the Qidni/D portable dialysis machine that performs hemodialysis without dialysate, purified water, or grid power, targeting the global population of kidney failure patients without access to conventional dialysis infrastructure.
- Ownership category
- akta.pro rank
Qidni Labs industry classification
Industry- Product category
- Medical Devices — Dialysis Equipment
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hemodialysis Machines & Systems (HLAHAKAA)
- akta.pro secondary industries
- Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges) (HLAHAKAH), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG)
Keywords
Where Qidni Labs is headquartered
LocationHeadquarters
- HQ city
- Buffalo
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Qidni Labs business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Qartridge™ Consumables: The Qartridge™ (Qidni cartridge) is a single-use disposable component for each dialysis session. Cost per treatment session is similar to current hemodialysis consumables cost. The company emphasizes they do not use expensive exotic materials in their cartridges.
- Qidni/D Device Sales: The Qidni/D flagship portable dialysis machine will be sold as a device. The company is pursuing licensing and partnership opportunities for distribution.
- Technology Licensing: The company is seeking licensing and partnership opportunities for their platform technology, which can be modified for applications beyond kidney dialysis for selective removal of target solutes from whole blood and other biofluids.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Qidni Labs product offering
Product offeringCore offering
Qidni Labs develops and plans to commercialize a portable, infrastructure-independent hemodialysis system comprising the Qidni/D miniaturized dialysis machine and the single-use Qartridge™ consumable. The system removes uremic toxins from whole blood without requiring dialysate, purified tap water, or AC power, enabling dialysis in rural areas, homes, disaster zones, battlefields, and satellite clinics while treatments are monitored remotely through a cloud-based clinical platform. The company is pre-commercial, pursuing FDA/Health Canada approval and actively seeking licensing and distribution partners.
Product overview
Qidni Labs offers a unified product portfolio centered on portable, accessible dialysis technology. The flagship product Qidni/D is a miniaturized dialysis machine that eliminates traditional infrastructure dependencies (no dialysate, no tap water, no electrical outlet required). This is powered by Qartridge™ technology, a proprietary selective blood purification cartridge that removes uremic toxins without the 120L of purified water needed in conventional hemodialysis. Together, these products enable dialysis in rural areas, disaster settings, military/battlefield environments, ambulances, satellite clinics, and homes where water and electricity infrastructure is unreliable or unavailable.
Differentiator
Problem solved
Functional benefit
Brands
- Qartridge™: Proprietary platform technology providing high capacity for selective absorption and removal of uremic toxins and other solutes from large volumes of whole blood. The first application is in kidney blood dialysis.
Products and services
- Qartridge™ Qartridge™ (Qidni cartridge) is a proprietary single-use disposable cartridge that provides high-capacity selective absorption and removal of uremic toxins and other solutes from large volumes of whole blood without requiring dialysate or large quantities of purified water. It is intended for use with the Qidni/D device to enable dialysis in settings where conventional water and dialysate infrastructure is unavailable, and the platform is also licensable for selective removal of target solutes from whole blood and other biofluids.
- Qidni/D Qidni/D is a miniaturized, portable hemodialysis machine designed to function as a "dialysis clinic in a dialysis machine." It operates without dialysate, tap water, water purification systems, or AC power (can run on rechargeable batteries), delivers 3–4 hour treatment sessions comparable to existing hemodialysis, and is monitored remotely by the clinical team via a cloud-based system. It targets use in rural areas, homes, satellite clinics, ambulances, disaster response, and military/battlefield settings.
Quantifiable outcome
- Water savings of 300-500L per treatment (equivalent to average person's daily water usage)
- +2 more outcomes
Companies that use Qidni Labs
Customer profileSegments7 records
Ideal customer profiles3 records
Qidni Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Qidni Labs partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- NATO-Ukraine Joint Analysis, Training and Education Centre (JATEC)coreJATEC selected Qidni Labs as one of nine companies to develop AI-based counter-drone solutions, medical systems, and autonomous defence technologies. JATEC is the first partner organization within NATO's structure with Ukraine holding equal status to member states. Based in Bydgoszcz, Poland.
- NATO Allied Command Transformation / JATECcoreQidni Labs won first place in NATO's 17th Innovation Challenge focused on battlefield medical innovation. Winners will advance toward rapid prototyping and field testing with Allied forces. NATO is prioritizing layered resilience and medical readiness adapted to drone surveillance, jamming, and extended evacuation delays.
- OC Innovation (Ontario Centre of Innovation)minorListed as a partner on Qidni Labs' Funding page. Ontario-based innovation organization supporting technology development.
- National Research Council Canada (NRC)minorListed as a partner on Qidni Labs' Funding page. Canadian government research organization supporting R&D.
- Canada Space Agency (ASC-CSA)minorListed as a partner on Qidni Labs' Funding page.
- MaRS Discovery DistrictminorListed as a partner on Qidni Labs' Funding page. Toronto-based innovation hub supporting startups.
- L-SparkminorListed as a partner on Qidni Labs' Funding page. Canadian accelerator for technology companies.
- KidneyXminorListed as a partner on Qidni Labs' Funding page. A public-private partnership to accelerate innovation in kidney care.
- NSERC (Natural Sciences and Engineering Research Council of Canada)minorListed as a partner on Qidni Labs' Funding page. Canadian federal research funding agency.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Qidni Labs competitors and assessment
Company assessmentEmerging players
- Diality: US-based developer of a portable hemodialysis system for home and acute care settings. Competes in the same miniaturized hemodialysis category as Qidni/D.
- AWAK Technologies: Singapore-based developer of a wearable peritoneal dialysis device. Comparable miniaturization thesis for portable dialysis, but on the PD rather than hemodialysis side.
Broad incumbents
- Medtronic: Diversified medtech incumbent with renal care exposure and adjacent therapeutic apheresis technology. Relevant as a potential strategic acquirer given Qartridge's platform applicability beyond dialysis.
- Fresenius Medical Care: Global leader in dialysis products and services (owns NxStage). Operates thousands of dialysis clinics and manufactures machines, dialyzers, and consumables — the dominant incumbent Qidni must eventually compete with or partner into.
- NxStage Medical (Fresenius): Pioneer in home hemodialysis (NxStage System One), now owned by Fresenius. Most analogous precedent for portable home hemodialysis market entry — useful comparator for Qidni's regulatory and adoption trajectory.
- DaVita: Largest US dialysis services provider operating thousands of outpatient clinics. Relevant for downstream channel access, payer relationships, and as a potential acquirer/licensor of portable dialysis innovations.
- Baxter International (Vantive kidney care): Major manufacturer of dialysis machines, PD systems (HomeChoice), and dialyzer consumables. Vantive spin-off (2024) focuses on kidney care — a likely strategic acquirer or competitor for Qidni's home/portable dialysis positioning.
Direct peers
- Outset Medical: Developer of Tablo, an FDA-cleared portable/home hemodialysis system with water purification and intuitive UX. Most directly comparable device competitor to Qidni/D in miniaturized dialysis for home and clinic settings.
- Quanta Dialysis Technologies: UK-based maker of Quanta Dialysis System, a small, portable hemodialysis device targeting home and clinic use. Directly comparable to Qidni's miniaturized dialysis machine thesis.
Others
- KidneyX: Public-private partnership between HHS and ASN accelerating kidney care innovation (already a Qidni partner). Useful ecosystem reference rather than a direct competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Qidni Labs social profiles
Digital presenceQidni Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Qidni Labs leadership team
Management profileNumber of profiles
Profiles1 record
Qidni Labs funding detail
Funding detailFunding overview
Funding rounds9 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Qidni Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Qidni Labs
What does Qidni Labs do?
Qidni Labs develops and plans to commercialize a portable, infrastructure-independent hemodialysis system comprising the Qidni/D miniaturized dialysis machine and the single-use Qartridge™ consumable. The system removes uremic toxins from whole blood without requiring dialysate, purified tap water, or AC power, enabling dialysis in rural areas, homes, disaster zones, battlefields, and satellite clinics while treatments are monitored remotely through a cloud-based clinical platform. The company is pre-commercial, pursuing FDA/Health Canada approval and actively seeking licensing and distribution partners.
Is Qidni Labs a public or private company?
Qidni Labs is a private company. It is classified as venture growth investor backed and is currently operating.
When was Qidni Labs founded?
Qidni Labs was founded in 2014. It employs 1 to 10 people.
Where is Qidni Labs based?
Qidni Labs is headquartered in Buffalo, United States, in the North America region.
How does Qidni Labs make money?
Three revenue lines are on record. Qartridge™ Consumables are the primary driver. The others are qidni/D Device Sales and technology Licensing.
Who are Qidni Labs's main competitors?
Emerging players on record are Diality and AWAK Technologies. Broad incumbents are Medtronic, Fresenius Medical Care, NxStage Medical (Fresenius), DaVita and Baxter International (Vantive kidney care). Direct peers are Outset Medical and Quanta Dialysis Technologies. KidneyX is listed as an others.
Does Qidni Labs have an API?
No public API is recorded for Qidni Labs.
What industry is Qidni Labs in?
Qidni Labs's product category is Medical Devices — Dialysis Equipment. Its primary akta.pro industry code is HLAHAKAA, Hemodialysis Machines & Systems, with a secondary code of HLAHAKAH, Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges). Its NAICS code is 3391 and its SIC code is 3845.